2010
DOI: 10.3345/kjp.2010.53.8.795
|View full text |Cite
|
Sign up to set email alerts
|

Increased B cell-activating factor (BAFF) level in the sputum of children with asthma

Abstract: PurposeB cell-activating factor (BAFF) is a tumor-necrosis factor (TNF) superfamily member best known for its role in the survival and maturation of B cells. BAFF activity is observed in naïve cells as well as in effector/memory T cells. We aimed to explore whether BAFF in sputum is expressed at elevated levels in asthmatic airways and associated with eosinophilic inflammation, pulmonary function, and bronchial hyperresponsiveness in children.MethodsOne hundred and fifty-four asthmatic children and 98 healthy … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
11
0

Year Published

2013
2013
2024
2024

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 17 publications
(11 citation statements)
references
References 20 publications
0
11
0
Order By: Relevance
“…Loss of BAFF impairs B cell development at the transitional stage from T1 B to T2 B cells, thereby decreasing the number of mature B cells and hence Ig level and autoantibodies (34). The expression of BAFF is elevated in patients with autoimmune diseases such as rheumatic arthritis, multiple sclerosis, SLE, and asthma, and belimumab, which is known as a mAb targeting human BAFF, has become the first approved targeted therapy for SLE (35)(36)(37). As a consequence, the way to inhibit BAFF has generated great potential to alleviate the phenotype of SLE.…”
Section: Discussionmentioning
confidence: 99%
“…Loss of BAFF impairs B cell development at the transitional stage from T1 B to T2 B cells, thereby decreasing the number of mature B cells and hence Ig level and autoantibodies (34). The expression of BAFF is elevated in patients with autoimmune diseases such as rheumatic arthritis, multiple sclerosis, SLE, and asthma, and belimumab, which is known as a mAb targeting human BAFF, has become the first approved targeted therapy for SLE (35)(36)(37). As a consequence, the way to inhibit BAFF has generated great potential to alleviate the phenotype of SLE.…”
Section: Discussionmentioning
confidence: 99%
“…For example, specific phenotypes of disease, such as B cell activating factor from the TNF family (BAFF) induced inflammatory diseases could be targeted through regulation of intracellular Ca 2+ level or CaMKII, AKT, or mTOR ultimately regulating autophagy and attenuating disease (155). Increased levels of BAFF have been observed in child asthma patients compared to healthy children (156). A variety of cytokines have been found to effect autophagy in B cells including IFN-α (153) and IL-4 (152).…”
Section: Ilc2mentioning
confidence: 99%
“…Increased Fc receptor‐like 5 ( FCRL5 ) expression in AA carrying the risk gene variants may point to reduced B‐cell regulation as this gene encodes for a membrane receptor found to bind IgG, thus negatively regulating B‐cell stimulation. Yet, this is surprising as B‐cell activation factor was previously upregulated in serum and sputum of asthma patients . As we could not additionally assess B cells in depth, we cannot conclude a direct influence of FCRL5 expression on B‐cell regulation in this cohort.…”
Section: Discussionmentioning
confidence: 79%